Chemours (CC)

• Market cap: $2.5B
• 1 day: -4.12%
• 5 days: -6.58%
• 1 month: -15.82%
• 3 months: -19.42%
• 6 months: -10.37%
• Year to date: 0.30%
• 1 year: -42.25%
• 5 years: -13.79%
• 10 years: -19.62%
• Sector: Materials
• Industry: Chemicals & Allied Products

About: The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Employees: 6,000

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

268% more call options, than puts

Call options by funds: $71.5M | Put options by funds: $19.4M

45% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 53

38% more repeat investments, than reductions

Existing positions increased: 139 | Existing positions reduced: 101

1.72% more ownership

Funds ownership: 82.55% [Q3] → 84.26% (+1.72%) [Q4]

2% more funds holding

Funds holding: 418 [Q3] → 425 (+7) [Q4]

15% less capital invested

Capital invested by funds: $2.5B [Q3] → $2.13B (-$376M) [Q4]

17% less funds holding in top 10

Funds holding in top 10: 6 [Q3] → 5 (-1) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $21 25% upside
• Avg. target: $24 42% upside
• High target: $27 61% upside

6 analyst ratings

• positive: 3 50%
• neutral: 3 50%
• negative: 0 0%

BMO Capital John McNulty 51% 1-year accuracy 25 / 49 met price target	61% upside $27	Outperform Maintained	19 Feb 2025
Truist Securities Peter Osterland 17% 1-year accuracy 1 / 6 met price target	61% upside $27	Buy Initiated	28 Jan 2025
Morgan Stanley Vincent Andrews 56% 1-year accuracy 5 / 9 met price target	31% upside $22	Equal-Weight Maintained	13 Jan 2025
Mizuho John Roberts 63% 1-year accuracy 22 / 35 met price target	25% upside $21	Neutral Maintained	7 Jan 2025
Goldman Sachs Duffy Fischer 67% 1-year accuracy 10 / 15 met price target	25% upside $21	Neutral Maintained	7 Jan 2025